ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Ablatus Therapeutics Limited

Ablatus Therapeutics Limited is a liquidation company incorporated on 7 October 2015 with the registered office located in Leeds, West Yorkshire. Ablatus Therapeutics Limited was registered 10 years ago.
Status
Liquidation
In voluntary liquidation since 1 year ago
Company No
09812865
Private limited company
Age
10 years
Incorporated 7 October 2015
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Overdue
Confirmation statement overdue by 378 days
Dated 6 October 2023 (2 years ago)
Next confirmation dated 6 October 2024
Was due on 20 October 2024 (1 year ago)
Last change occurred 2 years ago
Accounts
Overdue
Accounts overdue by 398 days
For period 1 Jan31 Dec 2022 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2023
Was due on 30 September 2024 (1 year 1 month ago)
Address
Brooklands Court
Phase 2 Office 9, Tunstall Road
Leeds
West Yorkshire
LS11 5HL
Address changed on 9 Sep 2025 (1 month ago)
Previous address was Unit 4 Madison Court George Mann Road Leeds West Yorkshire LS10 1DX
Telephone
Unreported
Email
Unreported
People
Officers
4
Shareholders
35
Controllers (PSC)
1
Director • Medical Director • British • Lives in England • Born in Apr 1975
Director • University Professor & Consultant Cardiologist • British • Lives in England • Born in Dec 1957
Director • Ceo • British • Lives in England • Born in Aug 1969
Director • Chief Executive • Malaysian • Lives in England • Born in Apr 1988
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Lombard Medical Limited
Dr Natalie Jayne Hayes is a mutual person.
Active
Health Enterprise East Limited
Dr Anne Dunlop Blackwood is a mutual person.
Active
PD And NJ Hayes Ltd
Dr Natalie Jayne Hayes is a mutual person.
Active
NJ Hayes Limited
Dr Natalie Jayne Hayes is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2022)
Period Ended
31 Dec 2022
For period 31 Dec31 Dec 2022
Traded for 12 months
Cash in Bank
£125.31K
Decreased by £254.68K (-67%)
Turnover
Unreported
Same as previous period
Employees
3
Increased by 1 (+50%)
Total Assets
£1.33M
Decreased by £288.22K (-18%)
Total Liabilities
-£21.3K
Decreased by £119.98K (-85%)
Net Assets
£1.31M
Decreased by £168.24K (-11%)
Debt Ratio (%)
2%
Decreased by 7.14% (-82%)
Latest Activity
Registered Address Changed
1 Month Ago on 9 Sep 2025
Registered Address Changed
1 Year Ago on 8 Oct 2024
Voluntary Liquidator Appointed
1 Year Ago on 7 Oct 2024
Notification of PSC Statement
1 Year 9 Months Ago on 31 Jan 2024
Mercia Asset Management Plc (PSC) Resigned
1 Year 9 Months Ago on 11 Jan 2024
Confirmation Submitted
2 Years Ago on 23 Oct 2023
Full Accounts Submitted
2 Years 5 Months Ago on 6 Jun 2023
Dr Looi Chung Yen Details Changed
2 Years 8 Months Ago on 16 Feb 2023
Dr Anne Dunlop Blackwood Details Changed
2 Years 11 Months Ago on 16 Nov 2022
Dr Looi Chung Yen Appointed
2 Years 12 Months Ago on 8 Nov 2022
Get Credit Report
Discover Ablatus Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Registered office address changed from Unit 4 Madison Court George Mann Road Leeds West Yorkshire LS10 1DX to Brooklands Court Phase 2 Office 9, Tunstall Road Leeds West Yorkshire LS11 5HL on 9 September 2025
Submitted on 9 Sep 2025
Registered office address changed from St. Johns Innovation Centre Cowley Road Cambridge Cambridgeshire CB4 0WS to Unit 4 Madison Court George Mann Road Leeds West Yorkshire LS10 1DX on 8 October 2024
Submitted on 8 Oct 2024
Statement of affairs
Submitted on 7 Oct 2024
Resolutions
Submitted on 7 Oct 2024
Appointment of a voluntary liquidator
Submitted on 7 Oct 2024
Resolutions
Submitted on 21 May 2024
Memorandum and Articles of Association
Submitted on 21 May 2024
Statement of capital following an allotment of shares on 16 May 2024
Submitted on 16 May 2024
Statement of capital following an allotment of shares on 27 February 2024
Submitted on 4 Mar 2024
Notification of a person with significant control statement
Submitted on 31 Jan 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year